Default company panoramic image

Silver Bullet Therapeutics, Inc.

Silver Bullet Therapeutics, has developed antimicrobial orthopedic implants for the prevention and treatment of bone based infections.

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location San Jose, CA, USA
  • Currency USD
  • Founded October 2009
  • Employees 6

Company Summary

There are over 1 million medical device related infections annually in the US that account for an estimated 64,000 deaths and an additional $3.8 billion in healthcare costs. To prevent these types of infections the company’s product utilizes an advanced Silver based technology for the prevention and treatment of bone-based infection, deformity and pain through the creation of antimicrobial orthopedic implants.


  • Default avatar
    Paul Chirico

    President & CEO and member Board of Directors, was most recently CEO of SpineAlign Medical. He has over 25 years in the medical device industry and has held senior management positions in Micrus, Avocet Medical, and Incyte Genomics (INCY)

  • Default avatar
    Bohdan Chopko

    Chief Neurosurgeon, MedCentral Health Systems in Mansfield, Ohio. He is also the Medical Director for the Neuroendovascular Surgery Laboratory in Mansfield, Ohio. Dr. Chopko is a Diplomate with the American Board of Neurological Surgery and Assistant Professor of Neurobiology, Division of Basic Medical Sciences, Northeastern Ohio Universities College of Medicine.

  • Default avatar
    Houdin Dehnad
    VP R&D

    was previously R&D Project Manager for Micrus Endovascular Corporation. Prior to Micrus, he was Project Leader & Senior R&D Engineer for Guidant Corporation and a Research Scientist with Alza Corporation. Dr. Dehnad has a Ph.D. in Biomedical & Chemical Engineering from the University of Minnesota, an M.S. in Biomedical Engineering from the University of Minnesota and a B.S. in Chemical Engineering from Washington University in St. Louis, MO.

  • Default avatar
    Chuck Boggs
    Dir. Corp. Dev.

    Mr. Boggs has 25+ yrs experience in senior level management in public, private & start-up companies. CEO at Myriad Concepts, he led the IPO on Toronto Exchange, he has served as a Senior Executive in a public company, and has served on the teams of over seven medical device start-ups.


  • Default avatar
    Casey McGlynn

Previous Investors

  • Default avatar
    23 individula investors, over $1.5M raised